Timothy C Barabe insider trades

Open-market stock purchases and sales by Timothy C Barabe, Director at Heartflow, Inc, from SEC Form 4 filings since Jan 21, 2010.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -34%.

Recent trades

DateStockTradeValue
Jul 22, 2026HTFL Heartflow, IncBought (not open market)—
Jul 17, 2026HTFL Heartflow, IncBought (not open market)—
Jun 16, 2026HTFL Heartflow, IncBought (not open market)$515K
Mar 11, 2026HTFL Heartflow, IncBought (not open market)—
Feb 17, 2026HTFL Heartflow, IncBought (not open market)—
Jan 2, 2026RNAC Cartesian Therapeutics, IncBought (not open market)—
Jan 2, 2026RNAC Cartesian Therapeutics, IncBought (not open market)—
Dec 4, 2025RNAC Cartesian Therapeutics, IncBought$206K

Companies traded

  • HTFL Heartflow, Inc: other filings, last Jul 22, 2026
  • RNAC Cartesian Therapeutics, Inc: 2 buys, last Jan 2, 2026
  • SELB Selecta Biosciences Inc: 8 buys, last Jan 2, 2023
  • VEEV Veeva Systems Inc: 12 sales, last Jun 22, 2021
  • ARQL Arqule Inc: other filings, last Jan 16, 2020
  • OPXA Opexa Therapeutics, Inc: 1 buy, 3 sales, last Nov 18, 2016
  • AFFX Affymetrix Inc: 11 buys, last Mar 18, 2013
  • HGSI Human Genome Sciences Inc: 2 sales, last Feb 22, 2010

Get free alerts when Timothy C Barabe files a new trade →